-
Mashup Score: 5Happy birthday, Dr Braunwald! - 1 day(s) ago
Eugene Braunwald was born in Vienna, Austria, in 1929 and recently celebrated his 95th birthday. He and his nuclear family escaped from Vienna when the Naz
Source: academic.oup.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 5Happy birthday, Dr Braunwald! - 2 day(s) ago
Eugene Braunwald was born in Vienna, Austria, in 1929 and recently celebrated his 95th birthday. He and his nuclear family escaped from Vienna when the Naz
Source: academic.oup.comCategories: General Medicine News, CardiologistsTweet-
https://t.co/MZzAJ2weaG
-
-
Mashup Score: 5Happy birthday, Dr Braunwald! - 2 day(s) ago
Eugene Braunwald was born in Vienna, Austria, in 1929 and recently celebrated his 95th birthday. He and his nuclear family escaped from Vienna when the Naz
Source: academic.oup.comCategories: General Medicine News, CardiologistsTweet-
https://t.co/MZzAJ2weaG
-
-
Mashup Score: 2Phenotypes and treatment outcomes in idiopathic pulmonary arterial hypertension patients with comorbidities - 2 day(s) ago
Idiopathic pulmonary arterial hypertension (IPAH) is often diagnosed in elderly patients with many comorbidities. Whereas a clear treatment strategy and risk assessment is recommended for patients with rare classical IPAH, monotherapy with phosphodiesterase type 5 inhibitors or endothelin receptor antagonists followed by regular follow-up and individualised therapy should be used for patients with many cardiopulmonary comorbidities. Here, we focus on these patients with IPAH and comorbidities, present a review of the literature with a focus on recently published work and summarise factors that may help to provide guidance for individualised treatment approaches in such patients.
Source: publications.ersnet.orgCategories: General Medicine News, CardiologistsTweet-
https://t.co/OKJKVcQbA9
-
-
Mashup Score: 16SciDraw | Scientific Drawings - 2 day(s) ago
SciDraw – an open repository of science drawings
Source: scidraw.ioCategories: General Medicine News, CardiologistsTweet-
I share with you some scientific-medical iconography websites of free access✨ 🔸https://t.co/syMbd5iHGv 🔸https://t.co/4KcKnAg85p 🔸https://t.co/oziWOqIIgJ Hope you find them useful for your presentations and projects‼️ Share this post with your community🤝
-
-
Mashup Score: 3
Right ventricular outflow dysfunction, manifesting as stenosis, regurgitation, or both, is nearly universal in patients with repaired tetralogy of Fallot, precipitating a complex pathophysiological cascade that leads to increasing rates of morbidity and mortality with advancing age. As the number of adolescent and adult patients with repaired tetralogy of Fallot continues to grow as a result of excellent survival during infancy, the need to improve late outcomes has become an urgent priority. This American Heart Association scientific statement provides an update on the current state of knowledge of the pathophysiology, methods of surveillance, risk stratification, and latest available therapies, including transcatheter and surgical pulmonary valve replacement strategies, as well as management of life-threatening arrhythmias. It reviews emerging evidence on the roles of comorbidities and patient-reported outcomes and their impact on quality of life. In addition, this scientific stateme
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet-
https://t.co/aw9KhSIjbW
-
-
Mashup Score: 8Pulmonary hypertension associated with left heart disease - 4 day(s) ago
Left heart disease (LHD) is the most common cause of pulmonary hypertension (PH), which may be classified further as isolated post-capillary (ipcPH) or combined post- and pre-capillary PH (cpcPH). The 7th World Symposium on Pulmonary Hypertension PH-LHD task force reviewed newly reported randomised clinical trials and contemplated novel opportunities for improving outcome. Results from major randomised clinical trials reinforced prior recommendations against the use of pulmonary arterial hypertension therapy in PH-LHD outside of clinical trials, and suggested possible harm. Greater focus on phenotyping was viewed as one general strategy by which to ultimately improve clinical outcomes. This is potentially achievable by individualising ipcPH versus cpcPH diagnosis for patients with pulmonary arterial wedge pressure within a diagnostic grey zone (12–18 mmHg), and through a newly developed PH-LHD staging system. In this model, PH accompanies LHD across four stages (A=at risk, B=structural
Source: publications.ersnet.orgCategories: General Medicine News, CardiologistsTweet-
https://t.co/5vSByZRsJu
-
-
Mashup Score: 8
Abstract. Patients presenting with or alerting emergency networks due to acute heart failure (AHF) form a diverse group with a plethora of symptoms, risks,
Source: academic.oup.comCategories: General Medicine News, CardiologistsTweet-
https://t.co/w3CnuSTenD
-
-
Mashup Score: 4Cardiogenic shock - 8 day(s) ago
Cardiogenic shock is a complex syndrome defined by systemic hypoperfusion and inadequate cardiac output arising from a wide array of underlying causes. Although the understanding of cardiogenic shock epidemiology, specific subphenotypes, haemodynamics, and cardiogenic shock severity staging has evolved, few therapeutic interventions have shown survival benefit. Results from seminal randomised controlled trials support early revascularisation of the culprit vessel in infarct-related cardiogenic shock and provide evidence of improved survival with the use of temporary circulatory support in selected patients.
Source: www.thelancet.comCategories: General Medicine News, CardiologistsTweet-
https://t.co/wunquNIg8L
-
-
Mashup Score: 4Cardiogenic shock - 8 day(s) ago
Cardiogenic shock is a complex syndrome defined by systemic hypoperfusion and inadequate cardiac output arising from a wide array of underlying causes. Although the understanding of cardiogenic shock epidemiology, specific subphenotypes, haemodynamics, and cardiogenic shock severity staging has evolved, few therapeutic interventions have shown survival benefit. Results from seminal randomised controlled trials support early revascularisation of the culprit vessel in infarct-related cardiogenic shock and provide evidence of improved survival with the use of temporary circulatory support in selected patients.
Source: www.thelancet.comCategories: General Medicine News, CardiologistsTweet-
https://t.co/wunquNIg8L
-
https://t.co/MZzAJ2weaG